Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen S. Galliker currently holds 36,039 shares of Galena Biopharma, Inc. (GALE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen S. Galliker has been a net seller of GALE stock. They have purchased $33.0K and sold $1.3M worth of shares.
Stephen S. Galliker's most recent insider trade was on Oct 10, 2017, when they sold 13,814 shares at $0.38 per share.
Stephen S. Galliker serves as Executive at Galena Biopharma, Inc. (GALE). They have executed 18 insider transactions totaling $1.4M over their tenure at the company.
Stephen S. Galliker holds the position of Executive at Galena Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Stephen S. Galliker has shown a selling trading pattern, with $33.0K in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen S. Galliker was on Feb 3, 2014, when they sold $1.3M worth of GALE shares. This transaction involved 300,000 shares at $4.18 per share.
Stephen S. Galliker currently owns 36,039 shares of Galena Biopharma, Inc. (GALE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen S. Galliker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen S. Galliker has 18 Form 4 filings on record as an insider at Galena Biopharma, Inc..
Set alerts for Stephen S. Galliker and 40,000+ other insiders.